Blb&B Advisors, LLC Danaher Corp Transaction History

Blb&B Advisors, LLC

  • $1.95 Billion
  • Q3 2024

A detailed history of Blb&B Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Blb&B Advisors, LLC holds 52,137 shares of DHR stock, worth $12.3 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
52,137
Previous 50,338 3.57%
Holding current value
$12.3 Million
Previous $12.6 Million 15.24%
% of portfolio
0.74%
Previous 0.69%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$239.25 - $280.76 $430,410 - $505,087
1,799 Added 3.57%
52,137 $14.5 Million
Q2 2024

Jul 26, 2024
BUY
$235.51 - $267.98 $1.65 Million - $1.88 Million
7,009 Added 16.18%
50,338 $12.6 Million
Q1 2024

Apr 26, 2024
BUY
$224.58 - $256.19 $186,850 - $213,150
832 Added 1.96%
43,329 $10.8 Million
Q4 2023

Jan 19, 2024
BUY
$185.1 - $233.13 $221,194 - $278,590
1,195 Added 2.89%
42,497 $9.83 Million
Q3 2023

Oct 24, 2023
BUY
$233.08 - $265.59 $6,293 - $7,170
27 Added 0.07%
41,302 $10.2 Million
Q2 2023

Jul 20, 2023
SELL
$224.99 - $256.14 $68,846 - $78,378
-306 Reduced 0.74%
41,275 $9.91 Million
Q1 2023

Apr 21, 2023
SELL
$239.75 - $277.0 $96,619 - $111,631
-403 Reduced 0.96%
41,581 $10.5 Million
Q4 2022

Jan 17, 2023
SELL
$241.42 - $282.29 $271,597 - $317,576
-1,125 Reduced 2.61%
41,984 $0
Q3 2022

Oct 14, 2022
BUY
$247.06 - $1507.4 $224,083 - $1.37 Million
907 Added 2.15%
43,109 $11.1 Million
Q2 2022

Jul 18, 2022
BUY
$237.11 - $299.66 $72,792 - $91,995
307 Added 0.73%
42,202 $10.7 Million
Q1 2022

Apr 20, 2022
BUY
$257.27 - $315.76 $458,969 - $563,315
1,784 Added 4.45%
41,895 $12.3 Million
Q4 2021

Jan 21, 2022
SELL
$292.08 - $329.01 $718,224 - $809,035
-2,459 Reduced 5.78%
40,111 $13.2 Million
Q3 2021

Oct 19, 2021
BUY
$272.21 - $332.43 $57,980 - $70,807
213 Added 0.5%
42,570 $13 Million
Q2 2021

Jul 20, 2021
BUY
$225.08 - $271.69 $111,189 - $134,214
494 Added 1.18%
42,357 $11.4 Million
Q1 2021

Apr 19, 2021
SELL
$212.38 - $245.9 $97,482 - $112,868
-459 Reduced 1.08%
41,863 $9.42 Million
Q4 2020

Jan 19, 2021
BUY
$212.5 - $245.46 $623,262 - $719,934
2,933 Added 7.45%
42,322 $9.4 Million
Q3 2020

Oct 20, 2020
BUY
$177.16 - $215.33 $274,775 - $333,976
1,551 Added 4.1%
39,389 $8.48 Million
Q2 2020

Jul 16, 2020
SELL
$128.7 - $176.83 $216,473 - $297,428
-1,682 Reduced 4.26%
37,838 $6.69 Million
Q1 2020

Apr 21, 2020
BUY
$121.39 - $169.05 $199,929 - $278,425
1,647 Added 4.35%
39,520 $5.47 Million
Q4 2019

Jan 21, 2020
BUY
$133.47 - $153.48 $128,131 - $147,340
960 Added 2.6%
37,873 $5.81 Million
Q3 2019

Oct 22, 2019
BUY
$135.4 - $146.47 $97,352 - $105,311
719 Added 1.99%
36,913 $5.33 Million
Q2 2019

Jul 29, 2019
SELL
$124.88 - $143.73 $177,204 - $203,952
-1,419 Reduced 3.77%
36,194 $5.17 Million
Q1 2019

Apr 19, 2019
BUY
$97.62 - $132.29 $324,098 - $439,202
3,320 Added 9.68%
37,613 $4.97 Million
Q4 2018

Jan 17, 2019
BUY
$94.85 - $109.54 $556,200 - $642,342
5,864 Added 20.63%
34,293 $3.54 Million
Q3 2018

Oct 12, 2018
BUY
$98.13 - $108.9 $316,567 - $351,311
3,226 Added 12.8%
28,429 $3.09 Million
Q2 2018

Jul 11, 2018
SELL
$96.1 - $103.24 $13,550 - $14,556
-141 Reduced 0.56%
25,203 $2.49 Million
Q1 2018

Apr 09, 2018
BUY
$92.16 - $103.8 $56,678 - $63,837
615 Added 2.49%
25,344 $2.48 Million
Q4 2017

Jan 16, 2018
BUY
$85.26 - $94.62 $29,841 - $33,117
350 Added 1.44%
24,729 $2.3 Million
Q3 2017

Oct 16, 2017
BUY
$79.29 - $88.45 $1.93 Million - $2.16 Million
24,379
24,379 $2.09 Million

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Blb&B Advisors, LLC Portfolio

Follow Blb&B Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blb&B Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blb&B Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email